ACTA1 and melanoma: TGF-β1, frequently found increased in sera of patients with malignant melanoma [102,120], is used by melanoma cells to modulate their surrounding stroma and stimulate the conversion of fibroblasts into α-SMA-expressing myofibroblasts and thus into CAFs (Figure 1) [101,121].